FLT3 and acute myeloid leukemia: FLT3 mutations appear in 25–35% of AML cases with either internal tandem duplications (FLT3-ITD) within the juxta membrane domain, or missense mutations affecting the second tyrosine kinase domain (FLT3-TKD2) [12].